Subscribe

Value Propositions

The following quotes were assembled from interviews and news coverage by FierceHealthFinance, revealing healthcare decision makers’ value-
based perspectives on some of the main problems currently facing providers and the US healthcare system:

The American Nurses Association (ANA) together with the Rheumatology Nurses Society issued a new guide to contemporary rheumatology nursing titled “Rheumatology Nursing,” which follows the establishment last year of rheumatology nursing as a new nursing specialty.
Early diagnosis of rheumatoid arthritis (RA) is particularly important for initiating early treatment and preventing joint damage in patients with RA. Researchers have recently discovered that the 14-3-3η protein can detect early inflammatory processes indicative of RA. “14-3-3η is a protein involved in many intracellular functions from cell proliferation to regulating the intracellular communication networks that are involved in various inflammatory processes relevant to rheumatoid arthritis,” according to Walter P. Maksymowych, MD, Consultant Rheumatologist and Professor of Medicine, University of Alberta, Canada.
Elevated levels of the biomarker β2 microglobulin (β2MG), a polypeptide found in saliva and serum, combined with sodium may be a new way to diagnose patients with Sjögren syndrome, according to a new study from Japan.
Results of a new study reported at EULAR 2013 indicate that replacing mycophenolate mofetil with the immunosuppressant drug azathioprine 6 weeks before conception in women with inactive lupus nephritis is safe and does not increase their risk for renal flares. Mycophenolate mofetil is often used in this patient population during pregnancy to protect the fetus.

A new study supported by the National Institutes of Health Pharmacogenomics Research Network represents a step forward toward personalized medicine in breast cancer prevention among women who are at high risk for the disease.

The new US Senate bill for the Veterans Affairs (VA) system provides $3.7 billion for the VA System information technology, which includes $251.9 million for an integrated electronic health record system and $119.4 million for the Veterans Benefits Management System claims systems.

Quality measures and patient satisfaction are increasingly being tied to a proportion of physicians’ reimbursement, according to a new report from the Medical Group Management Association-American College of Medical Practice Executives (MGMA-ACMPE), “Physician Compensation and Production Survey: 2013 Report Based on 2012 Data.”

Many presentations at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) focused on new research involving immunotherapy, including drugs for melanoma and lung cancer that have shown great success in prolonging life in patients with advanced disease. The number of immunotherapy drugs in development is growing, using different antibody mechanisms to identify and destroy cancer cells.

A new study led by researchers at the National Institutes of Health shows that a set of proteins in the body produces a large number of mutations in human DNA, indicating that these naturally produced mutations are just as powerful as cancer-causing agents in producing tumors. The proteins are part of the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) cytidine deaminases. The APOBEC mutations can outnumber all other mutations in some cancers.

Page 9 of 21
Results 81 - 90 of 206
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology